IndraLab

Statements


UCHL5 inhibits β-catenin inhibitors. 1 / 1
| 1

reach
"The ability of UCHL5 to promote metastasis can be increased by using β-catenin inhibitors or decreased by using β-catenin (Fig. 5B and D)."